Key Points - On May 30, 2025, Sely Medical (603716) closed at 12.54 yuan, down 1.72%, with a turnover rate of 23.81%, trading volume of 454,700 lots, and a transaction amount of 586 million yuan [1] - The net outflow of main funds was 20.84 million yuan, while retail investors saw a net inflow of 26.47 million yuan on the same day [1][3] Company Announcements - Sely Medical announced the establishment of a new special account for raised funds at Jiangsu Sushang Bank and the cancellation of the previous account at Guangfa Bank, which does not affect the investment plan for the raised funds [1][2][3] - The subsidiary Sely (Yunnan) Medical Supply Chain Management Co., Ltd. signed a four-party supervision agreement for the special account with China Construction Bank and the sponsor, Xinda Securities, ensuring that the funds are used solely for medical consumables centralized operation services [1]

Group 1 - The company has established a special account for the storage of raised funds and signed a four-party supervision agreement to ensure compliance with regulations and protect investors' rights [2][3] - The total amount raised from the issuance of convertible bonds is RMB 543.31 million, with a net amount of RMB 532.698 million after deducting related expenses [1] - The special account is exclusively for the use of funds related to the medical consumables centralized operation service project, and cannot be used for other purposes [3][4] Group 2 - The four-party supervision agreement involves the company, its subsidiary, the underwriting institution, and the bank, ensuring proper management of the raised funds [2][3] - The agreement stipulates that the underwriting institution will conduct ongoing supervision and can perform site investigations and inquiries regarding the special account [3][4] - The agreement will remain effective until all funds in the special account are fully utilized and the account is legally closed [4]

Group 1 - The company has established a special account for the storage of raised funds and signed a four-party supervision agreement to ensure compliance with regulations and protect investors' rights [1][2] - The total amount raised from the issuance of convertible bonds is RMB 543.31 million, with a net amount of RMB 532.698 million after deducting related expenses [1] - The special account is designated solely for the storage and use of funds related to the medical consumables centralized operation service (SPD) project [3][4] Group 2 - The four-party supervision agreement involves the company, its subsidiaries, the underwriting institution, and the bank, ensuring proper management of the raised funds [2][3] - The agreement stipulates that any funds stored in the account must not be used for purposes other than the specified project [3] - The underwriting institution is responsible for ongoing supervision and can conduct site investigations and inquiries regarding the use of the funds [3][4]